Literature DB >> 31656778

Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations.

Ming Li1, Cheng Zhan1.   

Abstract

Entities:  

Year:  2019        PMID： 31656778      PMCID： PMC6789357          DOI： 10.21037/atm.2019.07.22

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  21 in total

1.  Troubleshooting in advanced VATS procedures.

Authors:  Ayse Uzunel; René Horsleben Petersen
Journal:  Ann Transl Med       Date:  2019-06

Review 2.  Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors: New insights and approaches.

Authors:  H Tekatli; F O B Spoelstra; M Palacios; J van Sornsen de Koste; B J Slotman; S Senan
Journal:  Lung Cancer       Date:  2018-07-04       Impact factor: 5.705

3.  Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.

Authors:  Aadel A Chaudhuri; Chad Tang; Michael S Binkley; Michelle Jin; Jacob F Wynne; Rie von Eyben; Wendy Y Hara; Nicholas Trakul; Billy W Loo; Maximilian Diehn
Journal:  Lung Cancer       Date:  2015-05-04       Impact factor: 5.705

4.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

5.  Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer.

Authors:  Frank J Lagerwaard; Neil K Aaronson; Chad M Gundy; Cornelis J A Haasbeek; Ben J Slotman; Suresh Senan
Journal:  J Thorac Oncol       Date:  2012-07       Impact factor: 15.609

Review 6.  Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?

Authors:  Sarah Mahmood; Haris Bilal; Corinne Faivre-Finn; Rajesh Shah
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-30

7.  Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review.

Authors:  Hanbo Chen; Joanna M Laba; Sondos Zayed; R Gabriel Boldt; David A Palma; Alexander V Louie
Journal:  J Thorac Oncol       Date:  2019-05-07       Impact factor: 15.609

8.  Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.

Authors:  Richard J Cassidy; Pretesh R Patel; Xinyan Zhang; Robert H Press; Jeffrey M Switchenko; Rathi N Pillai; Taofeek K Owonikoko; Suresh S Ramalingam; Felix G Fernandez; Seth D Force; Walter J Curran; Kristin A Higgins
Journal:  Clin Lung Cancer       Date:  2017-03-16       Impact factor: 4.785

9.  Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.

Authors:  Stephen Abel; Shaakir Hasan; Richard White; Lana Schumacher; Gene Finley; Athanasios Colonias; Rodney E Wegner
Journal:  Lung Cancer       Date:  2018-12-24       Impact factor: 5.705

10.  Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Ming Li; Xiaodong Yang; Yuhan Chen; Xinyu Yang; Xiyu Dai; Fenghao Sun; Li Zhang; Cheng Zhan; Mingxiang Feng; Qun Wang
Journal:  Onco Targets Ther       Date:  2017-06-07       Impact factor: 4.147
View more
  1 in total

1.  Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I-IIIA non-small cell lung cancer: a propensity-matched analysis.

Authors:  Junjie Xi; Yajing Du; Zhengyang Hu; Jiaqi Liang; Yunyi Bian; Zhencong Chen; Qihai Sui; Cheng Zhan; Ming Li; Weigang Guo
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.